Diana P. Saraiva

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Diana P. Saraiva, António Jacinto, Paula Borralho et al. · Frontiers in Immunology · 2018 · 90 citations · Full text

A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion

Sílvia J. Bidarra, Patrícia Oliveira, Sara Rocha et al. · Scientific Reports · 2016 · 86 citations · Full text

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies

Diana P. Saraiva, Ana T. Matias, Sofía Braga et al. · Frontiers in Oncology · 2020 · 74 citations · Full text

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses

Diana P. Saraiva, Bruna Correia, Rute Salvador et al. · Oncotarget · 2021 · 37 citations · Full text

Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer

Diana P. Saraiva, Sofia Azeredo‐Lopes, Ana Antunes et al. · Cancers · 2021 · 36 citations · Full text

Hla-dr-expressing Ctls, Cancer Immunosurveillance, Breast Oncology +15